Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Fresenius Medical Care AG (FMS) over the last 16 years, with Q3 2025 value amounting to -$136.7 million.

  • Fresenius Medical Care AG's Change in Receivables fell 28693.13% to -$136.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$109.6 million, marking a year-over-year decrease of 36733.83%. This contributed to the annual value of -$243.6 million for FY2024, which is 25540.05% down from last year.
  • According to the latest figures from Q3 2025, Fresenius Medical Care AG's Change in Receivables is -$136.7 million, which was down 28693.13% from $118.6 million recorded in Q2 2025.
  • Over the past 5 years, Fresenius Medical Care AG's Change in Receivables peaked at $205.8 million during Q1 2021, and registered a low of -$136.7 million during Q3 2025.
  • Its 5-year average for Change in Receivables is $14.9 million, with a median of $8.7 million in 2021.
  • The largest annual percentage gain for Fresenius Medical Care AG's Change in Receivables in the last 5 years was 38175.07% (2022), contrasted with its biggest fall of 129673.18% (2022).
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Change in Receivables stood at $36.9 million in 2021, then skyrocketed by 381.75% to $177.6 million in 2022, then tumbled by 45.34% to $97.1 million in 2023, then crashed by 228.57% to -$124.8 million in 2024, then fell by 9.53% to -$136.7 million in 2025.
  • Its Change in Receivables was -$136.7 million in Q3 2025, compared to $118.6 million in Q2 2025 and $33.3 million in Q1 2025.